PROFILE |
 |
Drug giants Novartis and AstraZeneca have sold the farm. The European drug giants have spun off their respective agrochemical and seed businesses to create Syngenta, the world's largest agrochemical company. The move is the result of poor agrobusiness sales that stem, in part, from the controversy surrounding genetically modified seeds. Syngenta produces crop protection products (insecticides, herbicides, fungicides), field crop seeds (soybeans), vegetable seeds (corn, beans, tomatoes), and flowers. Syngenta and Myriad Genetics have mapped the rice genome, which could make rice crops more resistant to disease. As part of the spin-off, Novartis and AstraZeneca shareholders received 61% and 39% of Syngenta, respectively.
COMPETITION |
 |
Aventis (AVE)
E. I. du Pont de Nemours and Company (DD)
Monsanto Company (MON)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 4,876.00
1-Yr. Sales Growth: 4.2%
Employees: 24,921
Revenue per employee: $195,658.28
KEY PEOPLE |
 |
Michael Pragnell
CEO
Richard Jean-Paul Steiblin
CFO
CONTACT INFO |
 |
Schwarzwaldalle 215
4058 Basel, Switzerland
Phone: 41-61-697-1111
Fax: 41--
Online: Web Site
|